发明名称 |
2-methylene-19-nor-(20R)-1alpha-hydroxy-bishomopregnacalciferol |
摘要 |
<p>Disclosed is a vitamin D analogue having the formula I wherein X1 and X2 are independently selected from H and hydroxy protecting groups. Also disclosed is the use of the above compound in the preparation of a medicament for the treatment of a biological condition selected from psoriasis; leukaemia; colon cancer; breast cancer; prostate cancer; multiple sclerosis; lupus; diabetes mellitus; host versus graft reaction; rejection of organ transplants; an inflammatory disease selected from rheumatoid arthritis; asthma, or inflammatory bowel diseases; a skin condition selected from wrinkles, lack of adequate skin firmness, lack of adequate dermal hydration, or insufficient sebum secretion; renal osteodystrophy; or osteoporosis.</p> |
申请公布号 |
NZ555562(A) |
申请公布日期 |
2009.02.28 |
申请号 |
NZ20050555562 |
申请日期 |
2005.11.18 |
申请人 |
WISCONSIN ALUMNI RESEARCH FOUNDATION |
发明人 |
DELUCA, HECTOR F;PLUM, LORI A;CLAGETT-DAME, MARGARET |
分类号 |
(IPC1-7):C07C401/00 |
主分类号 |
(IPC1-7):C07C401/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|